When people are asked to choose who gets a life-saving vaccine, their answers don’t match the logic that drives most healthcare funding decisions.
Articles on NICE
Displaying 1 - 20 of 28 articles
Giving ministers more power over NHS drug pricing could reshape how public money is spent on health.
New weight loss jabs work brilliantly – but only while you’re taking them. The rebound is fast, and the cost-effectiveness unclear.
Lower back pain costs billions, but are we treating it right?
If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost down from around $500 a month to $31.60.
There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for Nice’s decision.
Have mental health apps lived up to their promise to offer tailored support in a challenging public health context? The answer is mixed.
Decolonising medicine will create a fairer healthcare system for all.
A new Nice guidance suggests exercise, talk therapy and acupuncture to treat chronic pain. Where does this leave those dependent on painkillers?
NHS drug budgets could rise by billions of pounds a year after a US-UK trade deal.
One in 20 patients referred to a cancer specialist by their GP don’t turn up.
NICE has concluded that more research is needed before it can recommend the use of cannabis based products for medicinal use.
Front line professionals need more support and time.
New findings show what the public really thinks about how we prioritise treatments at the end of people’s lives.
An increasing list of rare diseases can now be treated with gene therapy. But we need to figure out a way to make them affordable.
It’s time we considered the long-term benefits of community weight loss programmes to both individuals and society.
We can’t keep blaming the MMR-autism scare – there are other forces at play.
There is conflicting medical evidence.
Talking therapy for people with post-traumatic stress disorder is one suggestion. A new study finds that surfing may be beneficial too.
The Alzheimer’s Society is concerned that people with dementia aren’t getting diagnosed soon enough. But there are pros and cons to an early diagnosis.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Associate Professor in Cellular and Molecular Sciences, Northumbria University, Newcastle
-
Professor of epidemiology, University of Oxford
-
Associate professor, Queensland University of Technology
-
Research Fellow, Health Economics, Glasgow Caledonian University
-
Senior Investigator Scientist, University of Cambridge
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Career Development Fellow (Post-doctoral Research Associate), University of Cambridge
-
Senior lecturer in Immunology, University of Exeter
-
Senior Research Fellow at Veterans and Families Institute, Anglia Ruskin University
-
Professor, Washington State University
-
Professor of Molecular Oncology, University of Bradford
-
Professor of Health Economics, Glasgow Caledonian University
-
School of Social Sciences, Nottingham Trent University